Journal article
Cost-effectiveness benefits with formoterol turbuhaler twice daily versus salmeterol twice daily and as needed salbutamol
Abstract
The objective of this study was to compare the cost-effectiveness of formoterol Turbuhaler, twice daily, versus salmeterol pMDI, twice daily, or salbutamol pMDI, as needed, in patients being regularly treated with inhaled corticosteroids. This clinical study was a prospective, 12-week, randomised, open parallel group comparison of the three bronchodilators in 362 patients (>18 years) with moderate to severe asthma. All patients were symptomatic …
Authors
Berggren F; Svensson K; Rolnick MS; Alexander M; Mintz S
Journal
Thorax, Vol. 55, No. SUPPL. 3,
Publication Date
December 1, 2000
ISSN
0040-6376